Pediatric Echovirus Follow-up

  • Author: Jorge M Quinonez, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Nov 23, 2011
 

Further Outpatient Care

  • The specific type of infection caused by echovirus (EV) should dictate follow-up care.
Next

Prognosis

  • Neonates with disseminated encephalitis have a poor prognosis and many die. Children and older patients have a better prognosis, but the disease is occasionally fatal.
  • Acute myopericarditis is fatal in approximately 5% of cases; most patients recover without major sequelae.
  • The short-term prognosis for children with EV and enteroviral meningitis early in life appears to be good. The long-term prognosis for similarly affected children is controversial in regard to cognitive, developmental, and language abnormalities. Some recent prospective reports have indicated virtually no measurable long-term effects, even among patients with neurologic findings during their illness.
  • The prognosis is generally poor for patients with chronic meningoencephalitis who have coxsackievirus or EV infections and acquired or congenital B-lymphocyte function defects.
Previous
 
Contributor Information and Disclosures
Author

Jorge M Quinonez, MD  Senior Vice President and Chief Medical Officer, Family Health Centers of Southwest Florida, Inc

Jorge M Quinonez, MD is a member of the following medical societies: American Academy of Pediatrics and Infectious Diseases Society of America

Disclosure: Glaxo Smith Kline Consulting fee Speaking and teaching

Specialty Editor Board

Leonard R Krilov, MD  Chief of Pediatric Infectious Diseases and International Adoption, Vice Chair, Department of Pediatrics, Professor of Pediatrics, Winthrop University Hospital

Leonard R Krilov, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Medimmune Grant/research funds Cliinical trials; Medimmune Honoraria Speaking and teaching; Medimmune Consulting fee Consulting

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References

  1. Hauri AM, Schimmelpfennig M, Walter-Domes M, et al. An outbreak of viral meningitis associated with a public swimming pond. Epidemiol Infect. 2005;133:291-8. [Medline].

  2. Narkeviciute I, Vaiciuniene D. Outbreak of echovirus 13 infection among Lithuanian children. Clin Microbiol Infect. 2004;10:1023-5. [Medline].

  3. Somekh E, Cesar K, Handsher R, et al. An outbreak of echovirus 13 meningitis in Central Israel. Epidemiol Infect. 2003;130:257-62. [Medline].

  4. Chen JH, Chiu NC, Chang JC, et al. A neonatal echovirus 11 outbreak in an obstetric clinic. J Microbiol Immunol Infect. 2005;38:332-7. [Medline].

  5. Baek K, Yeo S, Lee B, Park K, Song J, Yu J, et al. Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009. Virol J. Jun 13 2011;8:297. [Medline]. [Full Text].

  6. Tryfonos C, Richter J, Koptides D, Yiangou M, Christodoulou CG. Molecular typing and epidemiology of enteroviruses in Cyprus, 2003-2007. J Med Microbiol. Oct 2011;60:1433-40. [Medline].

  7. Ke GM, Lin KH, Lu PL, Tung YC, Wang CF, Ke LY, et al. Molecular epidemiology of Echovirus 30 in Taiwan, 1988-2008. Virus Genes. Apr 2011;42(2):178-88. [Medline].

  8. Savolainen-Kopra C, Paananen A, Blomqvist S, Klemola P, Simonen ML, Lappalainen M, et al. A large Finnish echovirus 30 outbreak was preceded by silent circulation of the same genotype. Virus Genes. Feb 2011;42(1):28-36. [Medline].

  9. Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J. Jun 1999;18(6):533-7. [Medline].

  10. Sawyer MH, Holland D, Aintablian N, et al. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J. Mar 1994;13(3):177-82. [Medline].

  11. Schlesinger Y, Sawyer MH, Storch GA. Enteroviral meningitis in infancy: potential role for polymerase chain reaction in patient management. Pediatrics. Aug 1994;94(2 Pt 1):157-62. [Medline].

  12. Pevear DC, Tull TM, Seipel ME, Groarke JM. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. Sep 1999;43(9):2109-15. [Medline].

  13. National Institutes of Health. Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295AM2). Clinical Trials.gov. Available at http://www.clinicaltrials.gov/ct/gui/show/NCT00394914. Accessed May 9, 2008.

  14. Abzug MJ, Cloud G, Bradley J, et al. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003;22:335-41. [Medline].

  15. Abzug MJ. Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr Drugs. 2004;6:1-10. [Medline].

  16. Abzug MJ, Levin MJ, Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J. Oct 1993;12(10):820-4. [Medline].

  17. Cherry J. Enteroviruses. In: Remington J, Klein J, eds. Infectious Diseases of the Fetus and Newborn Infant. 1995. 4th ed. Philadelphia, Pa: WB Saunders Co; 404-46.

  18. Cherry J. Enteroviruses: Coxsackieviruses, Echoviruses and Polioviruses. In: Feigin R, Cherry J, eds. Textbook of Pediatric Infectious Diseases. 4th ed. Philadelphia, PA: WB Saunders Co; 1998:1787-839.

  19. Dagan R. Nonpolio enteroviruses and the febrile young infant: epidemiologic, clinical and diagnostic aspects. Pediatr Infect Dis J. Jan 1996;15(1):67-71. [Medline].

  20. Estrada B. Enteroviral Meningitis: Time for PCR?. Infect Med. 1999;16:493.

  21. Frisk G, Tuvemo T. Enterovirus infection with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies. J Med Virol. 2004;73:450-9. [Medline].

  22. Joki-Korpela P, Hyypia T. Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis. Jul 1998;27(1):129-36. [Medline].

  23. Krajden S, Middleton P. Enterovirus Infections in the Neonate. Clin Pediatr. 1982;22:87-92.

  24. Modlin J. Coxsackieviruses, echoviruses and newer enteroviruses. In: Mandell G, Bennett J, Dolin R. Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:1620-36.

  25. Modlin J. Enteroviruses: Coxsackieviruses, echoviruses, and newer enterovirus. In: Long S, Pickering L, Prober C, eds. Principles and Practice of Pediatric. ed. 1997.

  26. Modlin JF. Perinatal echovirus infection: insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries. Rev Infect Dis. Nov-Dec 1986;8(6):918-26. [Medline].

  27. Modlin JF. Update on enterovirus infections in infants and children. Adv Pediatr Infect Dis. 1996;12:155-80. [Medline].

  28. Onishi N, Hosoya M, Sato K, et al. First report of an outbreak of aseptic meningitis caused by echovirus type 13 in Japan. Pediatr Int. Aug 2003;45(4):494-6. [Medline].

  29. Paananen A, Ylipaasto P, Rieder E, et al. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol. 2003;69:529-37. [Medline].

  30. Pichichero ME, McLinn S, Rotbart HA, et al. Clinical and economic impact of enterovirus illness in private pediatric practice. Pediatrics. Nov 1998;102(5):1126-34. [Medline].

  31. Rabkin CS, Telzak EE, Ho MS, et al. Outbreak of echovirus 11 infection in hospitalized neonates. Pediatr Infect Dis J. Mar 1988;7(3):186-90. [Medline].

  32. Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. Apr 1995;20(4):971-81. [Medline].

  33. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Dis J. Dec 1999;18(12):1033-9; quiz 1040. [Medline].

  34. Shah SS, Gallagher PG. Neonatal sepsis due to echovirus 18 infection. J Perinat Med. 1997;25(4):381-4. [Medline].

  35. Verboon-Maciolek MA, Swanink CM, Krediet TG, et al. Severe neonatal echovirus 20 infection characterized by hepatic failure. Pediatr Infect Dis J. May 1997;16(5):524-7. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.